$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[미국특허] Use of asymmetric membranes in delivery devices 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/62
출원번호 US-0951931 (1992-09-25)
발명자 / 주소
  • Cardinal John R. (Groton CT) Herbig Scott M. (Groton CT) Korsmeyer Richard W. (Groton CT) Lo Jeelin (Groton CT) Smith Kelly L. (Groton CT) Thombre Avinash G. (Groton CT)
출원인 / 주소
  • Pfizer Inc. (New York NY 02)
인용정보 피인용 횟수 : 57  인용 특허 : 27

초록

A device for controlled release of an active substance through one or more asymmetric membranes by diffusion and/or osmotic pumping.

대표청구항

A process for preparing a tablet for controlled release of one or more active substances into an environment, said tablet comprised of a core of said active substances, with or without one or more excipients, surrounded by an asymmetric membrane selected from the group consisting of mono-, di- and t

이 특허에 인용된 특허 (27) 인용/피인용 타임라인 분석

  1. Dick Richard (2 ; rue Nicolas Houl 75005 Paris FRX) Le Jeune Andr (1 ; rue du 14 Juillet 28000 Mainvilliers FRX) Fournie Francois (37 ; rue La Quintinie 75015 Paris FRX), Asymmetric or composite polyquinoxaline base membranes, possible application to gaseous permeation and more particularly.
  2. Baker Richard William (Bend OR), Controlled release delivery system by an osmotic bursting mechanism.
  3. Ranade Gautam R. (East Lyme CT), Controlled release device for an active substance.
  4. Ventouras Kimon (Le Lignon CHX), Controlled release tablet.
  5. Lindahl Åke R. (Skurup SEX) Ekman Bo M. (MalmSEX), Controlled-release medical preparations.
  6. Theeuwes Felix (Los Altos CA), Device for dispensing drug by combined diffusional and osmotic operations.
  7. Deters Joseph C. (Mountain View CA) Wong Patrick S. L. (Hayward CA) Barclay Brian L. (Sunnyvale CA) Theeuwes Felix (Los Altos CA) Swanson David R. (Palo Alto CA), Dosage form for dispensing drug for human therapy.
  8. Wheatley Thomas A. (Richboro PA) Shah Rashminkumar S. (East Windsor NJ), Ethylcellulose-coated, gastric-disintegrable aspirin tablet.
  9. Kesting Robert E. (Irvine CA), Highly anisotropic membranes.
  10. Koide Tatsushi (Yawata JPX) Sasatani Seiei (Matsubara JPX) Inaba Kohji (Neyagawa JPX), Long-lasting three-layered pharmaceutical film preparations.
  11. Lindahl Ake R. (Skurup SEX) Erlandsson Stig A. B. (Malmo SEX), Membrane-coated sustained-release tablets and method.
  12. Lindahl Ake R. (Skurup SEX) Erlandsson Stig A. B. (Malmo SEX), Membrane-coated sustained-release tablets and method.
  13. Lindahl, Ake R.; Erlandsson, Stig A. B., Membrane-coated sustained-release tablets and method.
  14. Ichii Masaru (Tokyo JPX) Tani Shigeru (Tokyo JPX) Fukuda Kozo (Tokyo JPX), Method of producing plastic sheet with porous surface.
  15. Ayer Atul D. (Mt. View CA), Osmotic device comprising means for governing initial time of agent release therefrom.
  16. Theeuwes Felix (Los Altos CA) Barclay Brian (Menlo Park CA) Cortese Richard (San Jose CA), Osmotic device for dispensing two different medications.
  17. Theeuwes Felix (Los Altos CA), Osmotic device having microporous reservoir.
  18. Higuchi Takeru (Lawrence KS) Leeper Harold M. (Mountain View CA), Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient.
  19. Higuchi Takeru (Lawrence KS), Osmotic drug delivery system.
  20. Theeuwes Felix (Los Altos CA), Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina.
  21. Guittard George V. (Cupertino CA) Deters Joseph C. (Mountain View CA) Theeuwes Felix (Los Altos CA) Cortese Richard (San Jose CA), Osmotic system with instant drug availability.
  22. Theeuwes Felix (Los Altos CA), Osmotic system with volume amplifier for increasing amount of agent delivered therefrom.
  23. Theeuwes Felix (Los Altos CA) Damani Nalinkant C. (Sunnyvale CA), Osmotically driven active agent dispenser.
  24. Baker Richard W. (Mountain View CA) Brooke James W. (Sisters OR), Pharmaceutical delivery system.
  25. Thakore Yatin B. (East Brunswick NJ) Swanson Karen L. (Princeton NJ) Stoy Vladimir A. (Princeton NJ), Pressure-dependent anisotropic-transport membrane system.
  26. Wong Patrick S.-L. (Hayward CA), Programmable agent delivery system.
  27. Ayer Atul D. (Mt. View CA) Theeuwes Felix (Los Altos CA), Therapeutic device for osmotically dosing at controlled rate.

이 특허를 인용한 특허 (57) 인용/피인용 타임라인 분석

  1. Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
  2. Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
  3. Raaum, Erik Dean; Potter, Garrett Thomas; Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
  4. Raaum, Erik Dean; Potter, Garrett Thomas; Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
  5. Raaum, Erik Dean; Potter, Garrett Thomas; Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
  6. Raaum, Erik Dean; Potter, Garrett Thomas; Ly, Tai Wei, 3,5-diaminopyrazole kinase inhibitors.
  7. Cociorva, Oana; Li, Bei; Szardenings, Anna Katrin; Fukuda, Yasumichi; Nomura, Masahiro; Seto, Shigeki; Yumoto, Kazuhiro; Okada, Kyoko; Nakamura, Ayako, Aminoquinolones as GSK-3 inhibitors.
  8. Wise, David, Compositions and methods for treating pelvic pain and other conditions.
  9. Sudhakar, Anantha, Compounds and methods for treatment of cancer.
  10. Li, Bei; Szardenings, Anna Katrin, Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors.
  11. Venkatesh, Gopi M.; Vishnupad, Krishna S.; Percel, Phillip J., Extended release dosage forms of propranolol hydrochloride.
  12. Mapelli, Luigi; Fabiani, Flavio; Boltri, Luigi; Gatti, Paolo; Serratoni, Mauro; Cassanmagnago, Roberto, Fexofenadine microcapsules and compositions containing them.
  13. Mapelli, Luigi; Fabiani, Flavio; Boltri, Luigi; Gatti, Paolo; Serratoni, Mauro; Cassanmagnago, Roberto, Fexofenadine microcapsules and compositions containing them.
  14. Mapelli, Luigi; Fabiani, Flavio; Boltri, Luigi; Gatti, Paolo; Serratoni, Mauro; Cassanmagnago, Roberto, Fexofenadine microcapsules and compositions containing them.
  15. Loury, David J.; Buggy, Joseph J.; Mody, Tarak D.; Verner, Erik J.; Purro, Norbert; Balasubramanian, Sriram, Formulations of histone deacetylase inhibitor and uses thereof.
  16. Loury, David J.; Buggy, Joseph J.; Mody, Tarak D.; Verner, Erik J.; Purro, Norbert; Balasubramanian, Sriram, Formulations of histone deacetylase inhibitor and uses thereof.
  17. Loury, David J.; Buggy, Joseph J.; Mody, Tarak D.; Verner, Erik J.; Purro, Norbert; Balasubramanian, Sriram, Formulations of histone deacetylase inhibitor and uses therof.
  18. Loury, David J.; Buggy, Joseph J.; Mody, Tarak D.; Verner, Erik J.; Purro, Norbert; Balasubramanian, Sriram; Kloos, Ioana; Depil, Stephane, Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof.
  19. Caldwell, William Brett, Heterocyclic compounds and their uses.
  20. Harper, Derek J.; Milo, Charles F., Implantable osmotic pump.
  21. Ohta, Motohiro; Hayakawa, Eiji; Ito, Kunio; Tokuno, Sanji; Morimoto, Kiyoshi; Watanabe, Yasushi, Intrabuccally rapidly disintegrating tablet and a production method of the tablets.
  22. Ohta, Motohiro; Hayakawa, Eiji; Ito, Kunio; Tokuno, Sanji; Morimoto, Kiyoshi; Watanabe, Yasushi, Intrabuccally rapidly disintegrating tablet and a production method of the tablets.
  23. Ohta, Motohiro; Hayakawa, Eiji; Ito, Kunio; Tokuno, Sanji; Morimoto, Kiyoshi; Watanabe, Yasushi, Intrabuccally rapidly disintegrating tablet and a production method of the tablets.
  24. Ly, Tai Wei; Potter, Garrett Thomas, Isotopically enriched arylsulfonamide CCR3 antagonists.
  25. Ly, Tai Wei; Potter, Garrett Thomas, Isotopically enriched arylsulfonamide CCR3 antagonists.
  26. Abraham, Sunny; Chao, Qi; Hadd, Michael J.; Holladay, Mark W.; Liu, Gang; Setti, Eduardo, JAK kinase modulating compounds and methods of use thereof.
  27. Abraham, Sunny; Chao, Qi; Hadd, Michael J.; Holladay, Mark W.; Liu, Gang; Setti, Eduardo, JAK kinase modulating compounds and methods of use thereof.
  28. Abraham, Sunny; Chao, Qi; Hadd, Michael J.; Holladay, Mark W.; Liu, Gang; Setti, Eduardo, JAK kinase modulating compounds and methods of use thereof.
  29. Charles B. Nemeroff ; Clinton D. Kilts, Method and devices for transdermal delivery of lithium.
  30. Kuczynski, Anthony L.; Ayer, Atul Devdatt; Wong, Patrick S. L., Method for lowering blood glucose.
  31. Adimoolam, Shanthi; Buggy, Joseph J.; Magda, Darren; Miller, Richard, Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy.
  32. Estok, Thomas M.; Zaknoen, Sara L.; Mansfield, Robert K.; Lawhon, Tracy, Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders.
  33. Venkatesh, Gopi M.; Harmon, Troy M.; Taylor, John, Orally disintegrating tablets of atomoxetine.
  34. Kidane, Argaw; Ray, Shimul K.; Bhatt, Padmanabh P.; Bryan, Jr., Jones W., Osmotic delivery of therapeutic compounds by solubility enhancement.
  35. Derek J. Harper ; Charles F. Milo, Osmotic pump delivery system with flexible drug compartment.
  36. Am Ende, Mary T.; Roy, Michael C.; Smith, Scott W.; Waterman, Kenneth C.; Moses, Sara Kristen, Pharmaceutical compositions of 5,7,14-triazatetracyclo[10.3.1.0.0]-hexadeca-2(11),3,5,7,9-pentaene.
  37. Ly, Tai Wei; Raaum, Erik Dean, Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors.
  38. Hadd, Michael J.; Holladay, Mark W.; Rowbottom, Martin, Quinazoline compounds and methods of use thereof.
  39. Abraham, Sunny; Bhagwat, Shripad S.; Campbell, Brian T.; Chao, Qi; Faraoni, Raffaella; Holladay, Mark W.; Lai, Andiliy G.; Rowbottom, Martin W.; Setti, Eduardo; Sprankle, Kelly G., RAF kinase modulator compounds and methods of use thereof.
  40. Abraham, Sunny; Bhagwat, Shripad S.; Campbell, Brian T.; Chao, Qi; Faraoni, Raffaella; Holladay, Mark W.; Lai, Andiliy G.; Rowbottom, Martin W.; Setti, Eduardo; Sprankle, Kelly G., RAF kinase modulator compounds and methods of use thereof.
  41. Abraham, Sunny; Bhagwat, Shripad S.; Campbell, Brian T.; Chao, Qi; Faraoni, Raffaella; Holladay, Mark W.; Lai, Andiliy G.; Rowbottom, Martin W.; Setti, Eduardo; Sprankle, Kelly G., RAF kinase modulator compounds and methods of use thereof.
  42. Abraham, Sunny; Bhagwat, Shripad S.; Campbell, Brian T.; Chao, Qi; Faraoni, Raffaella; Holladay, Mark W.; Lai, Andiliy G.; Rowbottom, Martin W.; Setti, Eduardo; Sprankle, Kelly G., RAF kinase modulator compounds and methods of use thereof.
  43. Abraham, Sunny; Bhagwat, Shripad S.; Campbell, Brian T.; Chao, Qi; Faraoni, Raffaella; Holladay, Mark W.; Lai, Andiliy G.; Rowbottom, Martin W.; Setti, Eduardo; Sprankle, Kelly G., RAF kinase modulator compounds and methods of use thereof.
  44. Gross, Timothy David, Solid forms comprising optically active pyrazolylaminoquinazoline, compositions thereof, and uses therewith.
  45. Cociorva, Oana; Fukuda, Yasumichi; Kohno, Yasushi; Li, Bei; Okada, Kyoko; Nakamura, Ayako; Nomura, Masahiro; Seto, Shigeki; Szardenings, Anna Katrin; Yumoto, Kazuhiro, Spirocyclic aminoquinolones as GSK-3 inhibitors.
  46. Cociorva, Oana; Fukuda, Yasumichi; Kohno, Yasushi; Li, Bei; Okada, Kyoko; Nakamura, Ayako; Nomura, Masahiro; Seto, Shigeki; Szardenings, Anna Katrin; Yumoto, Kazuhiro, Spirocyclic aminoquinolones as GSK-3 inhibitors.
  47. Venkatesh, Gopi M., Taste-masked pharmaceutical compositions.
  48. Venkatesh, Gopi M., Taste-masked pharmaceutical compositions.
  49. Venkatesh, Gopi M., Timed, pulsatile release systems.
  50. Venkatesh, Gopi M., Timed, pulsatile release systems.
  51. Venkatesh, Gopi M., Timed, pulsatile release systems.
  52. Venkatesh, Gopi M., Timed, pulsatile release systems.
  53. Venkatesh, Gopi M., Timed, pulsatile release systems.
  54. Percel, Phillip J.; Vishnupad, Krishna S.; Venkatesh, Gopi M., Timed, sustained release systems for propranolol.
  55. Percel, Phillip J.; Vishnupad, Krishna S.; Venkatesh, Gopi M., Timed, sustained release systems for propranolol.
  56. Herbig, Scott Max; Krishnaswami, Sriram; Kushner, IV, Joseph; Lamba, Manisha; Stock, Thomas C, Tofacitinib oral sustained release dosage forms.
  57. McGee, Kevin; Zook, Scott; Carr, Andrew; Bonnaud, Thierry, Valbenazine salts and polymorphs thereof.

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 특허

해당 특허가 속한 카테고리에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로